Study Stopped
Due to lack of adequate patient sample size in a reasonable time period and lack of research support staff
Surgical Management of Knee Septic Arthritis
Open vs Arthroscopic Treatment of Septic Arthritis in the Adult Native Knee: A Prospective Trial
1 other identifier
interventional
10
1 country
1
Brief Summary
Surgical excisional debridement is the mainstay of management in septic arthritis with necessary decompression, lavage, debridement, and partial synovectomy. However, there has been considerable debate over the optimal modality. Most surgeons perform an open arthrotomy or arthroscopic debridement, although serial aspiration can be considered as an option in very limited circumstances with patients who cannot tolerate surgery. While open arthrotomy has been often utilized, there has been an increasing number of proponents for arthroscopic treatment citing lower re-infection rates and better functional outcomes. However, there has been a lack of well-designed prospective studies comparing surgical treatment modalities for native knee septic arthritis. The goals of this present study are to determine if arthroscopic management of septic arthritis in the native knee resulted in a lower number of surgeries and a shorter length of stay compared to open arthrotomy. Secondary outcomes included differences in postoperative pain and improvements in Lysholm knee scores.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 24, 2021
CompletedFirst Posted
Study publicly available on registry
March 8, 2021
CompletedStudy Start
First participant enrolled
April 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2022
CompletedDecember 8, 2023
December 1, 2023
1.1 years
February 24, 2021
December 1, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Number of surgeries to obtain lasting clinical resolution
The total number of surgeries performed during initial admission in order to obtain appropriate clinical response and resultant discharge on outpatient antibiotics.
Through time period of initial admission (days; expected under 14 days)
Hospital length of stay
The total number of days in which the patient is initially admitted in order to obtain appropriate clinical response and resultant discharge on outpatient antibiotics.
Through time period of initial admission (days; expected under 14 days)
Secondary Outcomes (3)
Post Operative Pain Scores
Through time period of initial admission (days; expected under 14 days)
Post Operative Opioid Use
Through time period of initial admission (days; expected under 14 days)
Lysholm Knee Scale
Through anticipated follow up period of 3 month post operative appointment.
Study Arms (1)
Patients with confirmed septic arthritis of the native knee
EXPERIMENTALInterventions
Patients with confirmed septic arthritis treated with multiple small incisions to perform irrigation and debridement with partial synovectomy.
Patients with confirmed septic arthritis treated with a single large incision, open arthrotomy to perform irrigation and debridement with partial synovectomy.
Eligibility Criteria
You may qualify if:
- Adults (\>18 years old)
- Have a diagnosis of septic arthritis of the native knee (synovial WBC \>50k or acrystalline elevated synovial WBC \>25,000 with high clinical suspicion)
- Willingness to participate in the study
You may not qualify if:
- Unwilling to participate in the study
- Acrystalline elevated synovial WBC \< 25,000
- Crystalline arthropathy with elevated synovial WBC but \< 50,000
- Have a history of a prior knee prosthesis (hemiarthroplasty, total knee arthroplasty)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Medical Center of El Paso
El Paso, Texas, 79905, United States
Related Publications (4)
Hunter JG, Gross JM, Dahl JD, Amsdell SL, Gorczyca JT. Risk factors for failure of a single surgical debridement in adults with acute septic arthritis. J Bone Joint Surg Am. 2015 Apr 1;97(7):558-64. doi: 10.2106/JBJS.N.00593.
PMID: 25834080BACKGROUNDBohler C, Dragana M, Puchner S, Windhager R, Holinka J. Treatment of septic arthritis of the knee: a comparison between arthroscopy and arthrotomy. Knee Surg Sports Traumatol Arthrosc. 2016 Oct;24(10):3147-3154. doi: 10.1007/s00167-015-3659-8. Epub 2015 May 28.
PMID: 26017744BACKGROUNDWirtz DC, Marth M, Miltner O, Schneider U, Zilkens KW. Septic arthritis of the knee in adults: treatment by arthroscopy or arthrotomy. Int Orthop. 2001;25(4):239-41. doi: 10.1007/s002640100226.
PMID: 11561499BACKGROUNDAim F, Delambre J, Bauer T, Hardy P. Efficacy of arthroscopic treatment for resolving infection in septic arthritis of native joints. Orthop Traumatol Surg Res. 2015 Feb;101(1):61-4. doi: 10.1016/j.otsr.2014.11.010. Epub 2015 Jan 23.
PMID: 25623272BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Adam Adler, MD
Texas Tech University Health Sciences Center of El Paso
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
February 24, 2021
First Posted
March 8, 2021
Study Start
April 1, 2021
Primary Completion
April 30, 2022
Study Completion
April 30, 2022
Last Updated
December 8, 2023
Record last verified: 2023-12